carbon monoxide has been researched along with Convalescence in 2 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Convalescence: The period of recovery following an illness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kantor, DB | 1 |
| Petty, CR | 1 |
| Phipatanakul, W | 1 |
| Gaffin, JM | 1 |
| Li, L | 1 |
| Sun, X | 1 |
| Wu, Q | 2 |
| Xing, Z | 1 |
| Yu, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| School Inner-City Asthma Intervention Study[NCT02291302] | 236 participants (Actual) | Interventional | 2015-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
[a comprehensive severity scale of day symptoms and albuterol use, night symptoms and albuterol use, controller treatment, lung function measures, and exacerbations], health care utilization, and pulmonary function testing (PFT's) including FEV1; FEV1/FVC, FEF25-75. CASI ranges from 0 (lowest) -20 points (highest) with a minimal clinically important difference of 0.49 points. The higher score is worse outcome. (NCT02291302)
Timeframe: 12 months
| Intervention | score on a scale (Mean) |
|---|---|
| Environmental Intervention | 2.9 |
| Sham and Control (Control) | 2.8 |
| Active Air Purifier and Control | 3.1 |
| Sham and Inegrated Pest | 2.9 |
Spirometry measure of forced expiration volume in 1 second (NCT02291302)
Timeframe: 12 months
| Intervention | percentage of predicted (Mean) |
|---|---|
| Environmental Intervention | 95.5 |
| Sham and Control (Control) | 99.2 |
| Active Air Purifier and Control | 97 |
| Sham and Inegrated Pest | 94.9 |
"Maximum number of~Days with wheezing, tightness in the chest, or cough and/or~Nights with disturbed sleep as a result of asthma and/or~Days on which the child had to slow down or discontinue play activities because of asthma This is defined as a cumulative assessment from the different variables listed in the Measure Description" (NCT02291302)
Timeframe: up to 12 months
| Intervention | days (Mean) |
|---|---|
| Environmental Intervention | 2.2 |
| Sham and Control (Control) | 2.7 |
| Active Air Purifier and Control | 1.2 |
| Sham and Inegrated Pest | 2.1 |
Number of school days missed because of asthma/ 2 weeks (NCT02291302)
Timeframe: 12 months
| Intervention | days/2 weeks (Mean) |
|---|---|
| Environmental Intervention | 0.15 |
| Sham and Control (Control) | 0.18 |
| Active Air Purifier and Control | 0.16 |
| Sham and Inegrated Pest | 0.07 |
1 trial available for carbon monoxide and Convalescence
| Article | Year |
|---|---|
Transcutaneous CO-oximetry differentiates asthma exacerbation and convalescence in children.
Topics: Adolescent; Asthma; Blood Gas Monitoring, Transcutaneous; Breath Tests; Carbon Monoxide; Child; Coho | 2018 |
1 other study available for carbon monoxide and Convalescence
| Article | Year |
|---|---|
[The lung function status in patients with severe acute respiratory syndrome after ten years of convalescence in Tianjin].
Topics: Adult; Aged; Carbon Monoxide; Convalescence; Female; Humans; Lung; Male; Middle Aged; Respiratory Fu | 2015 |